Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention

Cancer Letters

Volumn 355, Issue 1, 2014, Pages 9-17

  Shukla, Samriddhi ^a   Meeran, Syed M ^a   Katiyar, Santosh K ^b,c  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Cancer; DNA methylation; Epigenetics; Histone deacetylation; Phytochemicals

Indexed keywords

CATECHIN; CURCUMIN; DNA METHYLTRANSFERASE; EPICATECHIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; HISTONE DEACETYLASE; MICRORNA; PLANT MEDICINAL PRODUCT; POLYPHENOL; RESVERATROL; SULFORAPHANE; ANTINEOPLASTIC AGENT; HISTONE;

ANTINEOPLASTIC ACTIVITY; BIOCHEMICAL COMPOSITION; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER PREVENTION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DRUG EFFECT; ENZYME INHIBITION; EPIGENETICS; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; HISTONE ACETYLATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PANCREAS CANCER; PHYTOCHEMISTRY; PROSTATE CANCER; SHORT SURVEY; TEA; TUMOR SUPPRESSOR GENE; ACETYLATION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ACETYLATION; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; NEOPLASMS; PHYTOCHEMICALS;

EID: 84907984814     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.09.017     Document Type: Review

References (109)

1. Jones P.A., Gonzalgo M.L. Altered DNA methylation and genome instability: a new pathway to cancer?. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2103-2105.
2. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21:5427-5440.
3. Zagryazhskaya A., Zhivotovsky B. miRNAs in lung cancer: a link to aging. Ageing Res. Rev 2014, 17C:54-67. 10.1016/j.arr.2014.02.009.
4. Tekiner T.A., Basaga H. Role of microRNA deregulation in breast cancer cell chemoresistance and stemness. Curr. Med. Chem 2013, 20:3358-3369.
5. John K., Wu J., Lee B.W., Farah C.S. MicroRNAs in head and neck cancer. Int. J. Dent 2013, 2013:650218.
6. Nugent M. MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag. Res 2014, 6:15-25.
7. Katiyar S.K., Singh T., Prasad R., Sun Q., Vaid M. Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: interaction of bioactive dietary components on epigenetic targets. Photochem. Photobiol 2012, 88:1066-1074.
8. Tollefsbol T.O. Dietary epigenetics in cancer and aging. Cancer Treat. Res 2014, 159:257-267.
9. Meeran S.M., Ahmed A., Tollefsbol T.O. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin. Epigenetics 2010, 1:101-116.
10. Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem. Pharmacol 2010, 80:1771-1792.
11. Ratel D., Ravanat J.L., Berger F., Wion D. N6-methyladenine: the other methylated base of DNA. Bioessays 2006, 28:309-315.
12. Lopez-Serra L., Ballestar E., Fraga M.F., Alaminos M., Setien F., Esteller M. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res 2006, 66:8342-8346.
13. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet 2000, 24:88-91.
14. Nandakumar V., Vaid M., Tollefsbol T.O., Katiyar S.K. Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Carcinogenesis 2011, 32:597-604.
15. Prokhortchouk E., Hendrich B. Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?. Oncogene 2002, 21:5394-5399.
16. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem 2003, 278:4035-4040.
17. Muller A., Florek M. 5-Azacytidine/Azacitidine. Recent Results Cancer Res 2010, 184:159-170.
18. Momparler R.L., Cote S., Momparler L.F. Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C). Leuk. Res 2013, 37:980-984.
19. Kouzarides T. SnapShot: histone-modifying enzymes. Cell 2007, 131:822.
20. Dalvai M., Bystricky K. The role of histone modifications and variants in regulating gene expression in breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:19-33.
21. Wang C., Fu M., Mani S., Wadler S., Senderowicz A.M., Pestell R.G. Histone acetylation and the cell-cycle in cancer. Front. Biosci 2001, 6:D610-D629.
22. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med 2001, 7:437-443.
23. Chen X., Xiao W., Chen W., Luo L., Ye S., Liu Y. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis 2013, 4:e884.
24. Park S.Y., Jun J.A., Jeong K.J., Heo H.J., Sohn J.S., Lee H.Y., et al. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol. Rep 2011, 25:1677-1681.
25. Song C., Zhu S., Wu C., Kang J. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J. Biol. Chem 2013, 288:28021-28033.
26. Shukla S., Khan S., Tollefsbol T.O., Meeran S.M. Genetics and epigenetics of lung cancer: mechanisms and future perspectives. Curr. Cancer Ther. Rev 2013, 9:97-110.
27. Shukla S., Meeran S.M. Epigenetic factors in breast cancer progression. Breast Cancer Metastasis and Drug Resistance 2013, 341-365. Springer Publications, New York. A. Ahmad (Ed.).
28. Afaq F., Katiyar S.K. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev. Med. Chem 2011, 11:1200-1215.
29. Weng C.J., Yen G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev 2012, 38:76-87.
30. Khan N., Mukhtar H. Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem. Pharmacol 2013, 85:667-672.
31. Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr 2000, 71:1698S-1702S.
32. Katiyar S., Elmets C.A., Katiyar S.K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J. Nutr. Biochem 2007, 18:287-296.
33. Nandakumar V., Vaid M., Katiyar S.K. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32:537-544.
34. Meeran S.M., Katiyar S.K. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci 2008, 13:2191-2202.
35. Meeran S.M., Mantena S.K., Elmets C.A., Katiyar S.K. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res 2006, 66:5512-5520.
36. Baliga M.S., Meleth S., Katiyar S.K. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res 2005, 11:1918-1927.
37. Ahmad N., Cheng P., Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun 2000, 275:328-334.
38. Meeran S.M., Patel S.N., Chan T.H., Tollefsbol T.O. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev. Res 2011, 4:1243-1254.
39. Fang M., Wang Y., Ai N., Hou Z., Sun Y., Lu H., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003, 63:7563-7570.
40. Fang M., Chen D., Yang C. Dietary polyphenols may affect DNA methylation. J. Nutr 2007, 137:223S-228S.
41. Mittal A., Piyathilake C., Hara Y., Katiyar S.K. Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003, 5:555-565.
42. Mittal A., Pate M.S., Wylie R.C., Tollefsbol T.O., Katiyar S.K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol 2004, 24:703-710.
43. Berletch J.B., Liu C., Love W.K., Andrews L.G., Katiyar S.K., Tollefsbol T.O. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell. Biochem 2008, 103:509-519.
44. Gao Z., Xu Z., Hung M.S., Lin Y.C., Wang T., Gong M., et al. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res 2009, 29:2025-2030.
45. Kato K., Long N.K., Makita H., Toida M., Yamashita T., Hatakeyama D., et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer 2008, 99:647-654.
46. Kim S.O., Kim M.R. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int. J. Oncol 2013, 42:349-358.
47. Moseley V.R., Morris J., Knackstedt R.W., Wargovich M.J. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells. Anticancer Res 2013, 33:5325-5333.
48. Deb G., Thakur V.S., Limaye A.M., Gupta S. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol. Carcinog 2014, In press. 10.1002/mc.22121.
49. Li Y., Yuan Y.Y., Meeran S.M., Tollefsbol T.O. Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells. Mol. Cancer 2010, 9:274. http://www.molecular-cancer.com/content/9/1/274.
50. Wu D.S., Shen J.Z., Yu A.F., Fu H.Y., Zhou H.R., Shen S.F. Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. Oncol. Rep 2013, 30:2969-2975.
51. Saldanha S.N., Kala R., Tollefsbol T.O. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate. Exp. Cell Res 2014, 324:40-53.
52. Meeran S.M., Patel S.N., Li Y., Shukla S., Tollefsbol T.O. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS ONE 2012, 7:e37748.
53. Chen H., Landen C.N., Li Y., Alvarez R.D., Tollefsbol T.O. Enhancement of cisplatin-mediated apoptosis in ovarian cancer cells through potentiating G2/M arrest and p21 upregulation by combinatorial epigallocatechin gallate and sulforaphane. J. Oncol 2013, 2013:872957.
54. Dashwood R., Ho E. Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr. Rev 2008, 66S:S36-S38.
55. Myzak M.C., Karplus P.A., Chung F.L., Dashwood R.H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004, 64:5767-5774.
56. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H., Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood) 2007, 232:227-234.
57. Cheung K.L., Kong A.N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010, 12:87-97.
58. Dashwood R.H., Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol 2007, 17:363-369.
59. Ho E., Clarke J.D., Dashwood R.H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J. Nutr 2009, 139:2393-2396.
60. Meeran S.M., Patel S.N., Tollefsbol T.O. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE 2010, 5:e11457.
61. Hsu A., Wong C.P., Yu Z., Williams D.E., Dashwood R.H., Ho E. Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin. Epigenetics 2011, 3:3. 10.1186/1868-7083-3-3.
62. Zhang C., Su Z.Y., Khor T.O., Shu L., Kong A.N. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem. Pharmacol 2013, 85:1398-1404.
63. Su Z.Y., Zhang C., Lee J.H., Shu L., Wu T.Y., Khor T.O., et al. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Cancer Prev. Res 2014, 7:319-329.
64. Wong C.P., Hsu A., Buchanan A., Palomera-Sanchez Z., Beaver L.M., Houseman E.A., et al. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells. PLoS ONE 2014, 9:e86787.
65. Fu S., Kurzrock R. Development of curcumin as an epigenetic agent. Cancer 2010, 116:4670-4676.
66. Chen Y., Shu W., Chen W., Wu Q., Liu H., Cui G. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin. Pharmacol. Toxicol 2007, 101:427-433.
67. Meja K., Rajendrasozhan S., Adenuga D., Biswas S., Sundar I., Spooner G., et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am. J. Respir. Cell Mol. Biol 2008, 39:312-323.
68. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med. Chem 2006, 2:169-174.
69. Wada T.T., Araki Y., Sato K., Aizaki Y., Yokota K., Kim Y.T., et al. Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts. Biochem. Biophys. Res. Commun 2014, 444:682-686.
70. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther 2008, 7:464-473.
71. Bao B., Ali S., Banerjee S., Wang Z., Logna F., Azmi A.S., et al. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 2012, 72:335-345.
72. Saini S., Arora S., Majid S., Shahryari V., Chen Y., Deng G., et al. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res 2011, 4:1698-1709.
73. Banerjee S., Li Y., Wang Z., Sarkar F.H. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008, 269:226-242.
74. Singh A.V., Franke A.A., Blackburn G.L., Zhou J.R. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 2006, 66:1851-1858.
75. Su S.J., Yeh T.M., Chuang W.J., Ho C.L., Chang K.L., Cheng H.L., et al. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem. Pharmacol 2005, 69:307-318.
76. Sasamura H., Takahashi A., Yuan J., Kitamura H., Masumori N., Miyao N., et al. Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma. Urology 2004, 64:389-393.
77. Li Y., Chen H., Hardy T.M., Tollefsbol T.O. Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS ONE 2013, 8:e54369.
78. Li Y., Liu L., Andrews L.G., Tollefsbol T.O. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer 2009, 125:286-296.
79. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer 2008, 123:552-560.
80. Mirza S., Sharma G., Parshad R., Gupta S.D., Pandya P., Ralhan R. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J. Breast Cancer 2013, 16:23-31.
81. Zhang Y., Chen H. Genistein, an epigenome modifier during cancer prevention. Epigenetics 2011, 67:888-891.
82. Vanhees K., Coort S., Ruijters E.J., Godschalk R.W., van Schooten F.J., Barjesteh van Waalwijk van Doorn-Khosrovani S. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J. 2011, 25:797-807.
83. Majid S., Dar A.A., Ahmad A.E., Hirata H., Kawakami K., Shahryari V., et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30:662-670.
84. Raynal N.J., Charbonneau M., Momparler L.F., Momparler R.L. Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia. Oncol. Res 2008, 17:223-230.
85. Fang M., Chen D., Sun Y., Jin Z., Christman J., Yang C. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res 2005, 11:7033-7041.
86. Tang W.Y., Newbold R., Mardilovich K., Jefferson W., Cheng R.Y., Medvedovic M., et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 2008, 149:5922-5931.
87. Li Y., Meeran S.M., Patel S.N., Chen H., Hardy T.M., Tollefsbol T.O. Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol. Cancer 2013, 12. 10.1186/1476-4598-12-9.
88. Day J.K., Bauer A.M., DesBordes C., Zhuang Y., Kim B.E., Newton L.G., et al. Genistein alters methylation patterns in mice. J. Nutr 2002, 132:2419S-2423S.
89. Guerrero-Bosagna C.M., Sabat P., Valdovinos F.S., Valladares L.E., Clark S.J. Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice. BMC Physiol 2008, 8:17. 10.1186/1472-6793-8-17.
90. Qin W., Zhang K., Clarke K., Weiland T., Sauter E.R. Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue. Nutr. Cancer 2014, 66:270-277.
91. Mao Q.Q., Bai Y., Lin Y.W., Zheng X.Y., Qin J., Yang K., et al. Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mol. Nutr. Food Res 2010, 54:1574-1584.
92. Vanamala J., Reddivari L., Radhakrishnan S., Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 2010, 10:238. 10.1186/1471-2407-10-238.
93. Liu P.L., Tsai J.R., Charles A.L., Hwang J.J., Chou S.H., Ping Y.H., et al. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res 2010, 54:S196-S204.
94. Kraft T.E., Parisotto D., Schempp C., Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit. Rev. Food Sci. Nutr 2009, 49:782-799.
95. Papoutsis A.J., Selmin O.I., Borg J.L., Romagnolo D.F. Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol. Mol. Carcinog 2013, Epub ahead of print. 10.1002/mc.22095.
96. Wu M.L., Li H., Yu L.J., Chen X.Y., Kong Q.Y., Song X., et al. Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells. PLoS ONE 2014, 9:e89806.
97. Lea M.A., Randolph V.M., Patel M. Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. Int. J. Oncol 1999, 15:347-352.
98. Lea M.A., Randolph V.M., Lee J.E., desBordes C. Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. Int. J. Cancer 2001, 92:784-789.
99. Lea M.A., Rasheed M., Randolph V.M., Khan F., Shareef A., desBordes C. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutr. Cancer 2002, 43:90-102.
100. Druesne N., Pagniez A., Mayeur C., Thomas M., Cherbuy C., Duee P.H., et al. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 2004, 25:1227-1236.
101. Nian H., Delage B., Ho E., Dashwood R.H. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ. Mol. Mutagen 2009, 50:213-221.
102. Nian H., Delage B., Pinto J.T., Dashwood R.H. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis 2008, 29:1816-1824.
103. Meeran S.M., Vaid M., Punathil T., Katiyar S.K. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 2009, 30:520-528.
104. Mittal A., Elmets C.A., Katiyar S.K. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003, 24:1379-1388.
105. Nandakumar V., Singh T., Katiyar S.K. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 2008, 269:378-387.
106. Vaid M., Prasad R., Singh T., Jones V., Katiyar S.K. Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators. Toxicol. Appl. Pharmacol 2012, 263:122-130.
107. Lee W., Zhu B. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27:269-277.
108. King-Batoon A., Leszczynska J., Klein C. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen 2008, 49:36-45.
109. Paluszczak J., Krajka-Kuzniak V., Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett 2010, 192:119-125.